EVI is contributing to the global efforts to control these diseases in three main ways:
- Creating an environment to accelerate the development and clinical assessment of vaccine candidates for diseases of poverty
- Promoting affordability and accessibility of vaccines for diseases of poverty in low income populations
- Seeking to align all major stakeholders and acting as a focal point to ensure the successful development of vaccines for diseases of poverty for low income populations.
The EVI portfolio comprises four vaccine candidates under development, the coordination of five European Commission funded projects under the Sixth and Seventh Framework Programme, as well as one European and Developing Countries' Clinical Trials Partnership funded project.
EVI continues not only to have many successes in the clinical development of malaria vaccine candidates (its initial mandate as EMVI), but also in the coordination of projects funded by the European Commission (EC) and others. EVI is now embarking on vaccine candidates for other diseases of poverty in line with its wider mandate.
The TRANSVAC project has been highly successful, and the achievements to numerous to list all of them here. The greatest success, however, was the free access to all TRANSVAC services, which was provided to 29 high potential vaccine projects. To learn more, please activate the link above.